Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. (Q34333693)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. |
scientific article |
Statements
1 reference
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. (English)
1 reference
Thomas O'Hare
1 reference
Roy Pollock
1 reference
Eric P Stoffregen
1 reference
Jeffrey A Keats
1 reference
Omar M Abdullah
1 reference
Victor M Rivera
1 reference
Hao Tang
1 reference
Chester A Metcalf
1 reference
Regine S Bohacek
1 reference
Yihan Wang
1 reference
Raji Sundaramoorthi
1 reference
William C Shakespeare
1 reference
David Dalgarno
1 reference
Tim Clackson
1 reference
Tomi K Sawyer
1 reference
Michael W Deininger
1 reference
15 July 2004
1 reference
1 reference
104
1 reference
8
1 reference
2532-2539
1 reference
Identifiers
1 reference
1 reference